Herein, we analyzed publicly available gene expression datasets derived from 39 commonly used human NB cell lines representing MYCN-amplified and non-MYCN-amplified NB in an effort to identify pathways that are differentially regulated in MYCN-amplified NB tumors. This evidence concerns the gene MYCN and neuroblastoma.